Physician profile
Robert Bayless
NPI 1346287604
$29,639.38
in general payments reported to CMS, 2019-2025
31 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $617 · 2021: $455 · 2022: $286 · 2023: $831 · 2024: $9,205 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Consulting Fee: $11K · Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,648.33 |
| Consulting Fee | $11,200.00 |
| Food and Beverage | $2,184.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $25,283.30 | 2021-2025 | |
| Tracpatch Health, INC | $1,143.89 | 2019-2022 | |
| Pylant Medical | $617.15 | 2019-2022 | |
| Omnilife Science, INC | $503.73 | 2024 | Various Products, Omnibotics V 2.7 |
| Uoc USA INC | $294.09 | 2023 | U2, Conformity, U-Motion II and Ustar II |
| Smith+Nephew, INC. | $221.92 | 2021-2023 | Bone Anchors With Arthroscopic Delivery System |
| Shalby Advanced Technologies, INC. | $217.81 | 2023 | Tahoe Uni Knee System |
| Medtronic, INC. | $172.04 | 2022-2023 | Aquamantys(Tm) |
| Pacira Pharmaceuticals Incorporated | $166.57 | 2019-2024 | Zilretta, Exparel, Iovera |
| Depuy Synthes Sales INC. | $152.31 | 2019-2025 | Monovisc, Orthovisc |
| Abbvie INC. | $140.28 | 2025 | |
| Ferring Pharmaceuticals INC. | $92.40 | 2019-2025 | Euflexxa |
| Avanos Medical | $78.30 | 2022-2025 | Trivisc Sodium Hyaluronate |
| Bioventus LLC | $68.10 | 2019-2022 | |
| Molnlycke Health Care US, LLC | $63.87 | 2024-2025 | Mepilex Border Post-Op Ag, Exufiber Ag+, Avance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $60.73 | 2025 | Allograft Tissue, Biobrace 23mm |
| Nevro Corp. | $38.33 | 2019 | |
| Globus Medical, INC. | $37.89 | 2025 | Anthem, Autobahn |
| Ethicon US, LLC | $37.57 | 2024 | Stratafix |
| Pacira Therapeutics, INC. | $31.37 | 2019 | |
| Orthofix Medical, INC. | $29.66 | 2020-2023 | Physio-Stim |
| Medtronic USA, INC. | $26.61 | 2019 | |
| Electronic Waveform Lab, INC. | $23.84 | 2023-2024 | |
| Davol INC. | $23.11 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.66 | 2025 | |
| Averitas Pharma INC. | $20.44 | 2024 | Qutenza |
| Mimedx Group, INC. | $18.51 | 2024 | |
| Sanofi-Aventis U.S. LLC | $15.18 | 2020 | |
| Painteq LLC | $14.89 | 2022 | |
| Stryker Corporation | $14.70 | 2020 | |
| Fidia Pharma USA INC. | $9.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bayless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.